Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials

Date first appeared online	09/03/2019
DOI	10.1111/dom.13698
Authors	Bain S.
Journal Name	Diabetes, Obesity and Metabolism
Volume

Documents

• 49876.pdf , Book, Released under the terms of a Creative Commons Attribution-NonCommercial License (CC-BY-NC).